Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In Dictyostelium discoideum extracellular cAMP stimulates
guanylyl cyclase
and phospholipase C; the latter enzyme produces
Ins(1,4,5)P3
which releases Ca2+ from internal stores. The following data indicate that intracellular Ca2+ ions inhibit
guanylyl cyclase
activity. 1) In vitro, Ca2+ inhibits
guanylyl cyclase
with IC50 = 41 nM Ca2+ and Hill-coefficient of 2.1. 2) Extracellular Ca2+ does not affect basal cGMP levels of intact cells. In electro-permeabilized cells, however, cGMP levels are reduced by 85% within 45 s after addition of 10(-6) M Ca2+ to the medium; halfmaximal reduction occurs at 200 nM extracellular Ca2+. 3) Receptor-stimulated activation of
guanylyl cyclase
in electro-permeabilized cells is also inhibited by extracellular Ca2+ with half-maximal effect at 200 nM Ca2+. 4) In several mutants an inverse correlation exists between receptor-stimulated
Ins(1,4,5)P3
production and cGMP formation. We conclude that receptor-stimulated cytosolic Ca2+ elevation is a negative regulator of receptor-stimulated
guanylyl cyclase
.
...
PMID:Inhibition of receptor-stimulated guanylyl cyclase by intracellular calcium ions in Dictyostelium cells. 135 66
In Dictyostelium discoideum extracellular cAMP induces chemotaxis via a transmembrane signal transduction cascade consisting of surface cAMP receptors, G-proteins and effector enzymes including adenylyl cyclase,
guanylyl cyclase
and phospholipase C. Previously it was demonstrated that some cAMP derivatives such as 3'-deoxy-3'-aminoadenosine 3':5'-monophosphate (3'NH-cAMP) bind to the receptor and induce normal activation of adenylyl cyclase and
guanylyl cyclase
. However these analogues do not induce chemotaxis, probably because the signal is transduced in an inappropriate manner. We have now studied the regulation of phospholipase C by cAMP and these chemotactic antagonists. cAMP induced the two-fold activation of phospholipase C leading to a transient increase of
Ins(1,4,5)P3
levels. In contrast, the analogues induced a rapid decrease of intracellular
Ins(1,4,5)P3
levels, due to the inhibition of phospholipase C activity. In a transformed cell-line lacking the G-protein that mediates phospholipase C inhibition, 3'NH-cAMP did not decrease phospholipase C activity and was no longer an antagonist of chemotaxis. These results suggest that inhibition of phospholipase C leads to aberrant chemotaxis.
...
PMID:Chemotactic antagonists of cAMP inhibit Dictyostelium phospholipase C. 838 94
Aggregating Dictyostelium cells secrete cAMP during cell aggregation. cAMP induces two fast responses, the production of more cAMP (relay) and directed cell locomotion (chemotaxis). Extracellular cAMP binds to G-protein-coupled receptors leading to the activation of second messenger pathways, including the activation of adenylyl cyclase,
guanylyl cyclase
, phospholipase C and the opening of plasma membrane Ca2+ channels. Many genes encoding these sensory transduction proteins have been cloned and null mutants of nearly all components have been characterized in detail. Undoubtedly, activation of adenylyl cyclase is the most complex, involving G-proteins, a soluble protein called CRAC and components of the MAP kinase pathway. Null mutants in this pathway do not aggregate, but can exhibit chemotaxis and develop normally when supplied with exogenous cAMP. The pathways leading to the activation of phospholipase C were identified, but unexpectedly, deletion of the phospholipase C gene has no effect on chemotaxis and development, nor on intracellular
Ins(1,4,5)P3
levels; the metabolism of this second messenger will be discussed in some detail. Activation of
guanylyl cyclase
is G-protein-dependent and essential for chemotaxis. Analysis of a collection of chemotactic mutants reveals that most mutants are defective in either the production or intracellular detection of cGMP, thereby placing this second messenger at the center of chemotactic signal transduction. Analysis of the cAMP-mediated opening of plasma membrane calcium channels in signal transduction mutants suggests that it has two components, one that depends on G-proteins and intracellular cGMP and one that is G-protein-independent.
...
PMID:Transduction of the chemotactic cAMP signal across the plasma membrane of Dictyostelium cells. 853 2
C-type natriuretic peptide (CNP), the third member of the atrial natriuretic peptide family, acts via
guanylyl cyclase
containing GC-B receptors to stimulate cyclic guanosine 3',5' monophosphate (cGMP) accumulation in the gonadotrope-derived alphaT3-1 cell line and rat pituitary cells. This effect is inhibited by concomitant activation of the phospholipase C (PLC)-coupled gonadotrophin hormone-releasing hormone (GnRH) receptors in these cells. Since GnRH stimulates gonadotrophin secretion from gonadotropes by increasing the cytosolic Ca2+ concentration ([Ca2+]i) and natriuretic peptides have been found to influence PLC/Ca2+ signalling in other systems, we have investigated whether CNP can alter basal or GnRH-stimulated changes in [Ca2+]i in alphaT3-1 cells. In Ca 2+-containing medium, 10(-7) M CNP modestly, but significantly increased [Ca2+]i over several min, but subsequently inhibited the elevation of [Ca2+]i in response to 10(-7) M GnRH in both Ca2+-containing and Ca2+-free medium. This inhibitory effect was mimicked by 10(-6) M 8-Br-cGMP, but not by ANP, indicating mediation by cyclic GMP and the CNP-specific GC-B receptor. However, basal and GnRH-stimulated inositol (1,4,5) trisphosphate (
Ins(1,4,5)P3
) generation were not measurably affected by CNP, and CNP failed to affect thapsigargin-induced capacitative Ca2+ entry. Thus, it appears that the cross-talk between CNP and GnRH in these cells is reciprocal in that GnRH modulates CNP effects on cGMP generation, whereas, CNP modulates GnRH effects on Ca2+ mobilisation.
...
PMID:C-type natriuretic peptide (CNP) effects on intracellular calcium [Ca2+]i in mouse gonadotrope-derived alphaT3-1 cell line. 1053 7
This chapter describes biochemical assays with which to analyze signal transduction from surface cAMP receptors via G proteins to the effector enzymes adenylyl cyclase,
guanylyl cyclase
, and phospholipase C. The cAMP-mediated formation of the second messengers cAMP, cGMP, and
Ins(1,4,5)P3
in cells will provide information on the entire pathway; here, details on isotope-dilution assays, through which the concentrations of these second messengers can be determined, are offered. Subsequently, several assays that analyze specific parts of the sensory transduction pathway are described. The assays include equilibrium and nonequilibrium binding to surface cAMP receptors on cells and on isolated membranes. The interaction between the cAMP receptor and G proteins can be measured as GTPgammaS-mediated inhibition of cAMP-binding to the receptor, or as cAMP-mediated stimulation of GTPase activity or GTPgammaS-binding to G proteins. Finally, assays for the in vitro G protein-mediated activation of the effector enzymes adenylyl cyclase,
guanylyl cyclase
, and phospholipase C are described.
...
PMID:Analysis of signal transduction: formation of cAMP, cGMP, and Ins(1,4,5)P3 in vivo and in vitro. 1695 2